If you are thinking about selling your privately-owned chemicals or life sciences business, it’s likely that there are several items vying for the top spot on your list of priorities.
Amongst maximising price, optimising deal structure, and securing a good home for employees – there are many factors at play in a typical divestment strategy.
It’s less common, however, for speed to rank highly as a concern for many sellers. Finding the right deal is rightly considered as the primary objective, and an emphasis on completing the process quickly may seem counter-intuitive to the concept of working patiently towards a successful completion.
In fact, speed has a critical role to play – in particular, minimising the length of time from first talking to potential buyers through to completion, in other words, your time “on the market”.
The more time a business is “on the market” the higher the risks and costs.
The following risks and costs all generally increase with time:
The overall aim is to minimise the time the business is “on the market”. This means every stage of a successful sale - from business preparation through buyer engagement and due diligence - should be optimised with this aim in mind.
Once “on the market”, speed of execution ranks among several key factors which can have a dramatic impact on the ability of shareholders to realise the full value of their business.
Careful planning and preparation for a sale process that moves swiftly once buyers are engaged, minimises opportunities for value erosion and deal failure. As Benjamin Franklin once said –
“An ounce of prevention is worth a pound of cure.”
Thank you for contacting us.
We will get back to you as soon as possible.
Oops, there was an error sending your message.
Please try again later.